Translation, Notarisation and Consular Authentication

1. Key takeaways

This is the most underrated stage of a Cambodian project and the one most likely to send the whole dossier back for rework. Section 2.3 of the DDF Guidelines for Registration of Therapeutic Products in Cambodia (1 August 2019, 190 pages) sets out clear rules:

1. Applications and supporting documents must be clearly printed in English, French or Khmer;
2. Documents in any other language must be accompanied, in addition to the original, by a certified or notarised full translation;
3. The applicant or the marketing authorisation holder is responsible for the accuracy of the translation;
4. The authentication of the translation must be done at the nearest consulate of Cambodia in the country from where the document originates (Authentication of the translation has to be done at the nearest consulate of Cambodia in the country from where the document originates).

Section 2.2.3 adds technical requirements for PDFs: they must be searchable (not un-OCR’d scanned images), not encrypted, accompanied by a cloud-drive link and access password when over 50 MB, and bookmarked.

The two rule sets — language and format — fail in different ways. Language failures are usually visible late: a document proceeds through preparation and internal review, and the missing translation or the missing authentication is discovered when the set is assembled. Format failures are visible early but persist: a PDF that scans as an image, or one left encrypted by a generation tool, survives until a reviewer tries to search it. Building both checks into the same pre-submission review — one by document, one by file — closes both windows at once.

GRZAN note: the language rule offers 3 choices (English / French / Khmer); the authentication venue carries 1 hard requirement — the nearest consulate of Cambodia in the country where the document originates; the PDF technical requirements number 4.

2. Legal basis

3. Expert insights

1. The rule ‘authentication at the nearest consulate of Cambodia in the country of document origin’ directly drives the project schedule. Certificates of Free Sale, ISO certificates, LoAs, DoCs and similar documents issued in the manufacturer’s own country must have their translations authenticated at a consulate of Cambodia in that country. Notarisation and authentication therefore form a serial chain that cannot run in parallel: original issued, then translation, then notarisation, then consular authentication. A delay in any link pushes the whole submission back, and in Cambodia that can mean a missed committee window.

1. ‘The applicant is responsible for translation accuracy’ is a responsibility-allocation clause. Even a notarised translation leaves accuracy with the applicant — that is, the local licence-holding entity. The local entity therefore has a real incentive to review translations substantively; overseas manufacturers should supply a glossary and the source text side by side to cut the back-and-forth.

1. The translation quality of device terminology is itself a review risk. Khmer medical-device terminology is less standardised than English. A translator unfamiliar with device terms easily introduces ambiguity, which can lead reviewers to misread the intended use — and intended use directly determines the class. This is the hidden link between translation quality and classification outcomes.

1. The consular authentication venue rule also has a portfolio dimension. A manufacturer submitting to several countries with different authentication requirements may find that the same certificate needs parallel authentication tracks, and that the track for Cambodia is the one bound to a specific consular geography — the country where the document originates. Consolidating issuance of the core certificates (Certificate of Free Sale, ISO certificates, LoA, DoC) in one issuing country, where that reflects the real arrangement, simplifies the chain; spreading issuance across countries multiplies consular steps for no documentary benefit.

1. Translation and dossier preparation should be sequenced with the classification outcome in mind. The passages that matter most — intended use, contraindications, warnings and precautions — are exactly the passages fixed by the classification decision. Translating them before the classification is settled risks redoing the work; translating after the wording is frozen lets the glossary do its job once. This is one more reason the authentication chain needs its own schedule: it should start from frozen source text, not from text still moving.

4. Practical recommendations

1. Set the notarisation-to-consular-authentication chain as the critical path with its own schedule. Do not count it as running in parallel with document preparation. At project kick-off, confirm the current requirements and processing times with the consulate of Cambodia in the country where the documents are issued.
2. Give the translator a bilingual glossary. Build a side-by-side table of the key terms — product names, models, materials, intended use, warnings — and hand it over with the originals to reduce ambiguity.
3. Have the local entity’s technical staff double-check the finished translation. Focus on the four passages — intended use, contraindications, warnings and precautions — which bear directly on classification and labelling compliance.

5. Verification checklist

• □ All applications and supporting documents in English, French or Khmer
• □ Documents not in English/French/Khmer carry the original plus a certified or notarised full translation
• □ Translations authenticated at the nearest consulate of Cambodia in the country of document origin
• □ Current requirements and processing times confirmed with the consulate and built into the critical path
• □ PDFs meet all four requirements: searchable, unencrypted, bookmarked, cloud link for files over 50 MB
• □ Translations of intended use, contraindications, warnings and precautions re-checked by the local entity’s technical staff

Regulatory information verified as of 29 October 2026.

In Southeast Asia, GRZAN’s core capabilities focus on three areas. First, tracking the legislative progress of dedicated medical-device laws across member states — Singapore, Malaysia, Thailand, Indonesia, the Philippines and Vietnam have each established written device regulatory frameworks, whereas Cambodia still has no dedicated Medical Device Act; the current rules are pieced together from three layers: the registration-number legal basis provided by the Law on Drug Management 1996 and its 2007 amendment, the classification and procedures provided by Prakas No. 1258 (2012), and the technical framework provided by the ASEAN Medical Device Directive, so compliance certainty is markedly lower than in markets that have completed legislation. Second, local authorised representative services: GRZAN can act as the manufacturer’s statutory representative in Cambodia, handling registration submissions, regulatory communication and post-market reporting obligations, and assisting with the practical arrangements for a Cambodian registered pharmacist and the licence for pharmaceutical import and export enterprises. Third, quality-system and testing support: GRZAN assists in establishing a quality management system conforming to ISO 13485 and in organising the technical dossier under the ASEAN Common Submission Dossier Template (CSDT).

Business enquiries: info@grzanglobal.com